Morgan Stanley Research expects that the global market for treatments of type-2 diabetes and obesity could reach $190 billion by 2035, $40 billion more than previously estimated
With more generic pharmaceuticals hitting the market, the glucagon-like peptide 1 (GLP-1) agonists market is expected to develop in the region
Additionally, GLP-1RAs exhibit organ-protective effects on the heart, brain, kidneys, lungs, liver, intestines and vasculature in the context of septic multi-organ dysfunction
With the right approach, you can navigate the challenges of GLP-1 side effects and continue your path to better health with confidence
They did this by providing alcohol 3 days per week
Gigliotti L, Warshaw H, Evert A, Dawkins C, Schwartz J, Susie C, Kushner R, Subramanian S, Handu D, Rozga M